???global.info.a_carregar???
Peter Jervis is an experienced Research Chemist with a demonstrated history of working in both academia and the pharmaceutical industry (AstraZeneca, GlaxoSmithKline, Concept Life Sciences). He also has extensive experience in university teaching, scientific writing, editing and proofreading. He has published over 30 peer-reviewed research papers in international journals. He is a strong research professional, with a PhD in Organic and Medicinal Chemistry from the University of Birmingham. He has extensive experience presenting oral communications at various scientific meetings and congresses. He is skilled in organic chemistry, asymmetric synthesis, NMR spectroscopy, liquid chromatography-mass spectrometry (LC-MS), and natural product research. His current research interests are in the chemical synthesis and biological evaluation of peptidomimetics. For more information, see https://orcid.org/0000-0002-5550-4535 or https://www.linkedin.com/in/peterjervis6/. Highlights: – Wide-ranging experience in organic chemistry and medicinal chemistry research. – 34 papers published in international peer-reviewed journals (15 as first author, 7 as corresponding author). Some of these papers are in high-ranking journals, such as Immunity (IF: 30), Nature Immunology (IF: 31), Journal of Clinical Investigation (IF: 19), Cancer Research (IF: 13) and PNAS (IF: 13). – Experienced in university chemistry teaching, including lectures, tutorials, workshops and laboratory demonstrating. Use of some innovative teaching methods, such as enquiry-based learning. – Experienced in designing chemistry modules and end of course assessments, e.g. NMR introductory course for foundation year students and retrosynthesis course for final year students.
Ler resumo completo ↓
Identificação

Identificação pessoal

Nome completo
Peter Jervis
Género
Masculino

Nomes de citação

  • Jervis, Peter J
  • Jervis PJ

Identificadores de autor

Ciência ID
1719-37A3-4AA2
ORCID iD
0000-0002-5550-4535
Scopus Author Id
15020526900

Endereços de correio eletrónico

  • peterjervis@quimica.uminho.pt (Profissional)
  • peterjervis6@gmail.com (Pessoal)

Websites

Domínios de atuação

  • Ciências Exatas - Química - Química Orgânica
  • Ciências Médicas e da Saúde - Medicina Básica - Química Médica
  • Ciências Naturais - Ciências Biológicas - Bioquímica

Idiomas

Idioma Conversação Leitura Escrita Compreensão Peer-review
Inglês (Idioma materno)
Português Utilizador independente (B1) Utilizador independente (B1) Utilizador independente (B1) Utilizador independente (B1)
Espanhol; Castelhano Utilizador independente (B1) Utilizador independente (B2) Utilizador independente (B2) Utilizador independente (B1)
Formação
Grau Classificação
2004/09/01 - 2008/06/01
Concluído
 Organic Chemistry (Doctor of Philosophy)
University of Birmingham School of Chemistry, Reino Unido
"Stereoselective Intramolecular Allylation Routes to Oxygen-Containing Heterocycles - Supervisor: Dr. Liam R. Cox - Stereoselective synthesis of THPs/THFs via intramolecular reaction of an allylsilane and an aldehyde - Total synthesis of aureonitol" (TESE/DISSERTAÇÃO)
2000/09/01 - 2004/07/01
Concluído
 Chemistry (Master)
University of Leicester Department of Chemistry, Reino Unido
"Classification: First Class Honours (combined 4-year bachelors's/masters) - Final year project: The synthesis of 2,6-dideoxy- and 2,6-dideoxy-6-fluoro-sugars (Prof. Jonathon M. Percy) - Completed total synthesis of olivose and 6-fluoro-olivose" (TESE/DISSERTAÇÃO)
 First Class Honours
Percurso profissional

Ciência

Categoria Profissional
Instituição de acolhimento 		Empregador
2019/05/23 - 2021/11/22 Investigador (Investigação) Universidade do Minho, Portugal
Universidade do Minho, Portugal
2018/07/09 - 2019/05/21 Investigador (Investigação) Universidade do Porto Faculdade de Farmácia, Portugal
Universidade do Porto Faculdade de Farmácia, Portugal
2017/10/01 - 2018/07/06 Investigador (Investigação) AstraZeneca UK Ltd Macclesfield, Reino Unido
AstraZeneca UK Ltd Macclesfield, Reino Unido
2016/06/01 - 2017/09/30 Investigador (Investigação) Concept Life Sciences Chapel-en-le-Frith, Reino Unido
Concept Life Sciences Chapel-en-le-Frith, Reino Unido
2014/09/01 - 2015/10/31 Investigador (Investigação) GlaxoSmithKline España, Espanha
GlaxoSmithKline España, Espanha
2008/05/01 - 2014/08/31 Investigador (Investigação) University of Birmingham School of Biosciences, Reino Unido
University of Birmingham School of Biosciences, Reino Unido
Projetos

Bolsa

Designação Financiadores
2022/05/25 - 2022/12/24 BIOIMAGE CTO-21 - "Novos biomarcadores de imagem na avaliação de oclusãos coronarianas totais crônicas"
UMINHO/BIM-CNCG/2022/82
Investigador
Universidade do Minho, Portugal
Em curso
2014/09/01 - 2015/10/31 Novel Inhibitors of Mycobacteria Tuberculosis Enzymes
GSK Open Lab
Bolseiro de Cientista Convidado
GlaxoSmithkline Investigación y Desarrollo, Espanha
 GlaxoSmithKline Open Lab Foundation
2008/05/01 - 2014/08/31 Studying the Immune Response following Glycolipid Presentation by CD1d protein to iNKT cells
Wellcome-Trust
Bolseiro de Pós-Doutoramento
University of Birmingham School of Biosciences Centre for Systems Biology, Reino Unido
 Wellcome-Trust
Concluído
2004/09/01 - 2008/06/01 Stereoselective Intramolecular Allylation Routes to Oxygen-Containing Heterocycles
EPSRC PhD studentship
Bolseiro de Doutoramento
Engineering and Physical Sciences Research Council
Concluído

Projeto

Designação Financiadores
2018/07/01 - 2021/06/30 Self-assembled minimalist peptide hydrogels inspired by mussel adhesive proteins for biomedical applications
FCT – PTDC/QUI-QOR/29015/2017
Investigador
Fundação para a Ciência e a Tecnologia
2018/07/10 - 2019/05/20 New Technologies for three Health Challenges of Modern Societies: Diabetes, Drug Abuse and Kidney Diseases
NORTE-01-0145-FEDER-000024
Investigador
Fundação para a Ciência e a Tecnologia
Produções

Publicações

Artigo em conferência
  1. Jervis PJ; Moreira R; Ferreira PMT; Martins JA; Pereira DM. "'Self-Delivery' Using Anti-Inflammatory Hydrogels: Biological Evaluation of NSAID-Dehydrodipeptide Conjugates". 2020.
    10.3390/iocn2020-07897
  2. Amorim, C; Jervis PJ; Andrade J; Ferreira PMT; Martins JA. "Synthesis and characterisation of dimeric bolaamphiphilic dehydrodipeptides for biomedical applications.". 2020.
    10.3390/iocn2020-07994
Artigo em revista
  1. Daniela Correia da Silva; Peter J. Jervis; José A. Martins; Patrícia Valentão; Paula M.T. Ferreira; David M. Pereira. "Fisetin derivatives exhibit enhanced anti-inflammatory activity and modulation of endoplasmic reticulum stress". International Immunopharmacology 119 (2023): 110178-110178. http://dx.doi.org/10.1016/j.intimp.2023.110178.
    10.1016/j.intimp.2023.110178
  2. Suzanne E. Engelen; Francesca A. Ververs; Angela Markovska; Christoffer Lagerholm; Jordan Kraaijenhof; Laura I.E. Yousif; Yasemin-Xiomara Zurke; et al. "Lipoproteins act as vehicles for lipid antigen delivery and activation of invariant natural killer T-cells". JCI Insight (2023): http://dx.doi.org/10.1172/jci.insight.158089.
    10.1172/jci.insight.158089
  3. Carlos Oliveira; Valéria Gomes; Paula MT Ferreira; J.A. Martins; Peter J. Jervis. Autor correspondente: Peter J. Jervis. "Peptide-Based Supramolecular Hydrogels as Drug Delivery Agents: Recent Advances". Gels (2022): https://www.mdpi.com/2310-2861/8/11/706.
    10.3390/gels8110706
  4. Carlos Oliveira; Renato Pereira; David Pereira; loic hilliou; Tarsila G. Castro; J.A. Martins; Peter J. Jervis; Paula MT Ferreira. Autor correspondente: Peter J. Jervis. "Aryl-Capped Lysine-Dehydroamino Acid Dipeptide Supergelators as Potential Drug Release Systems". International Journal of Molecular Sciences (2022): https://www.mdpi.com/1422-0067/23/19/11811.
    10.3390/ijms231911811
  5. Peter J. Jervis. Autor correspondente: Peter J. Jervis. "Hydrogels in Regenerative Medicine and Other Biomedical Applications". International Journal of Molecular Sciences (2022): https://www.mdpi.com/1422-0067/23/6/3270.
    10.3390/ijms23063270
  6. Carlos B.P. Oliveira; Sérgio R.S. Veloso; Castanheira, Elisabete M. S.; Figueira, Pedro; Carvalho, Alexandra; hilliou, loic; Pereira, Renato B.; et al. Autor correspondente: Jervis, Peter. "An injectable, naproxen-conjugated, supramolecular hydrogel with ultra-low critical gelation concentration - prepared from a known folate receptor ligand". Soft Matter 18 20 (2022): 3955-3966. http://dx.doi.org/10.1039/d2sm00121g.
    10.1039/d2sm00121g
  7. Amorim C; Veloso SRS; Castanheira EMS; Hilliou L; Pereira RB; Pereira DM; Martins JA; Jervis PJ; Ferreira PMT. Autor correspondente: Jervis PJ. "Bolaamphiphilic Bis-Dehydropeptide Hydrogels as Potential Drug Release Systems". Gels (2021): https://www.mdpi.com/2310-2861/7/2/52.
    Acesso aberto • 10.3390/gels7020052
  8. Veloso SRS; Jervis PJ; Silva JFG; Hilliou L; Moura C; Pereira DM; Coutinho PJG; et al. "Supramolecular ultra-short carboxybenzyl-protected dehydropeptide-based hydrogels for drug delivery". Materials Science and Engineering: C 122 (2021): 111869. http://dx.doi.org/10.1016/j.msec.2021.111869.
    10.1016/j.msec.2021.111869
  9. Jervis PJ; Amorim C; Pereira T; Martins JA; Ferreira PMT. Autor correspondente: Jervis PJ. "Dehydropeptide Supramolecular Hydrogels and Nanostructures as Potential Peptidomimetic Biomedical Materials". International Journal of Molecular Science (2021): https://www.mdpi.com/1422-0067/22/5/2528.
    10.3390/ijms22052528
  10. Jervis PJ; Hilliou L; Pereira RB; Pereira DM; Martins JA; Ferreira PMT. Autor correspondente: Jervis PJ. "Evaluation of a Model Photo-Caged Dehydropeptide as a Stimuli-Responsive Supramolecular Hydrogel". Nanomaterials (2021): https://www.mdpi.com/2079-4991/11/3/704.
    10.3390/nano11030704
  11. Kharkwal SS; Johndrow CT; Veerapen N; Kharkwal H; Saavedra-Avila NA; Carreño LJ; Rothberg S; et al. "Serial Stimulation of Invariant Natural Killer T Cells with Covalently Stabilized Bispecific T Cell Engagers Generates Anti-Tumor Immunity While Avoiding Anergy". Cancer Research (2021): canres.2219.2020. http://dx.doi.org/10.1158/0008-5472.can-20-2219.
    10.1158/0008-5472.can-20-2219
  12. Moreira R; Jervis PJ; Carvalho A; Ferreira, PMT; Martin JA; Valentao P; Andrade PB; Pereira DM. Autor correspondente: Jervis PJ. "Biological Evaluation of Naproxen–Dehydrodipeptide Conjugates with Self-Hydrogelation Capacity as Dual LOX/COX Inhibitors". Pharmaceutics (2020): http://dx.doi.org/10.3390/pharmaceutics12020122.
    10.3390/pharmaceutics12020122
  13. Velosa SRS; Martins JA; Hilliou L; Amorim CO; Amaral VS; Almeida BG; Jervis PJ; et al. "Dehydropeptide-based plasmonic magnetogels: a supramolecular composite nanosystem for multimodal cancer therapy". Journal of Materials Chemistry B (2020): http://dx.doi.org/10.1039/c9tb01900f.
    10.1039/c9tb01900f
  14. Jervis PJ; Amorim C; Pereira T; Martins JA; Ferreira PMT. "Exploring the properties and potential biomedical applications of NSAID-capped peptide hydrogels". Soft Matter 16 44 (2020): 10001-10012. http://dx.doi.org/10.1039/d0sm01198c.
    10.1039/d0sm01198c
  15. Veerapen N; Kharkwal SS; Jervis P; Bhowruth V; Besra AK; North SJ; Haslam SM; et al. "Photoactivable Glycolipid Antigens Generate Stable Conjugates with CD1d for Invariant Natural Killer T Cell Activation.". Bioconjugate chemistry (2018): http://europepmc.org/abstract/med/30085659.
    10.1021/acs.bioconjchem.8b00484
  16. Cox JA; Mugumbate G; Del Peral LV; Jankute M; Abrahams KA; Jervis P; Jackenkroll S; et al. "Novel inhibitors of Mycobacterium tuberculosis GuaB2 identified by a target based high-throughput phenotypic screen.". Scientific reports (2016): http://europepmc.org/abstract/med/27982051.
    10.1038/srep38986
  17. Saez de Guinoa J; Jimeno R; Farhadi N; Jervis PJ; Cox LR; Besra GS; Barral P. "CD1d-mediated activation of group 3 innate lymphoid cells drives IL-22 production.". EMBO reports (2016): http://europepmc.org/abstract/med/27799287.
    10.15252/embr.201642412
  18. Cox JA; Abrahams KA; Alemparte C; Ghidelli-Disse S; Rullas J; Angulo-Barturen I; Jervis PJ; et al. "THPP target assignment reveals EchA6 as an essential fatty acid shuttle in mycobacteria.". Nature microbiology (2016): http://europepmc.org/abstract/med/27571973.
    10.1038/nmicrobiol.2015.6
  19. Dossa RG; Alperin DC; Garzon D; Mealey RH; Brown WC; Jervis PJ; Besra GS; Cox LR; Hines SA. "In contrast to other species, a-Galactosylceramide (a-GalCer) is not an immunostimulatory NKT cell agonist in horses.". Developmental and comparative immunology (2014): http://europepmc.org/abstract/med/25445911.
    10.1016/j.dci.2014.11.005
  20. Venkataswamy MM; Ng TW; Kharkwal SS; Carreño LJ; Johnson AJ; Kunnath-Velayudhan S; Jervis PJ; et al. "Improving Mycobacterium bovis bacillus Calmette-Guèrin as a vaccine delivery vector for viral antigens by incorporation of glycolipid activators of NKT cells.". PloS one (2014): http://europepmc.org/abstract/med/25255287.
    10.1371/journal.pone.0108383
  21. Arora P; Baena A; Yu KO; Saini NK; Kharkwal SS; Goldberg MF; Jervis PJ; et al. "A single subset of dendritic cells controls the cytokine bias of natural killer T cell responses to diverse glycolipid antigens.". Immunity (2014): http://europepmc.org/abstract/med/24412610.
    10.1016/j.immuni.2013.12.004
  22. Jervis PJ; Polzella P; Wojno J; Jukes JP; Ghadbane H; Garcia Diaz YR; Besra GS; Cerundolo V; Cox LR. "Design, synthesis, and functional activity of labeled CD1d glycolipid agonists.". Bioconjugate chemistry (2013): http://europepmc.org/abstract/med/23458425.
    10.1021/bc300556e
  23. Nguyen TK; Koets AP; Vordermeier M; Jervis PJ; Cox LR; Graham SP; Santema WJ; et al. "The bovine CD1D gene has an unusual gene structure and is expressed but cannot present a-galactosylceramide with a C26 fatty acid.". International immunology (2012): http://europepmc.org/abstract/med/22968995.
    10.1093/intimm/dxs092
  24. Jervis PJ; Graham LM; Foster EL; Cox LR; Porcelli SA; Besra GS. "New CD1d agonists: synthesis and biological activity of 6"-triazole-substituted a-galactosyl ceramides.". Bioorganic & medicinal chemistry letters 22 13 (2012): 4348-4352. http://europepmc.org/abstract/med/22652050.
    Acesso aberto • Publicado • 10.1016/j.bmcl.2012.05.009
  25. Salio M; Ghadbane H; Shepherd D; Cypen J; Aichinger M; Jervis PJ; Besra GS; Cresswell P; Cerundolo V. "Combined functional and kinetic measurements to address the role of saposins in loading CD1d molecules with iNKT cell agonists". Molecular Immunology 51 1 (2012): 38-39. http://dx.doi.org/10.1016/j.molimm.2012.02.116.
    10.1016/j.molimm.2012.02.116
  26. Jervis PJ; Moulis M; Jukes JP; Ghadbane H; Cox LR; Cerundolo V; Besra GS. "Towards multivalent CD1d ligands: synthesis and biological activity of homodimeric a-galactosyl ceramide analogues.". Carbohydrate research (2012): http://europepmc.org/abstract/med/22445102.
    10.1016/j.carres.2012.02.034
  27. Jervis PJ; Cox LR; Besra GS. "Synthesis of a versatile building block for the preparation of 6-N-derivatized a-galactosyl ceramides: rapid access to biologically active glycolipids.". The Journal of organic chemistry (2010): http://europepmc.org/abstract/med/21155575.
    10.1021/jo102064p
  28. Jervis PJ; Veerapen N; Bricard G; Cox LR; Porcelli SA; Besra GS. "Synthesis and biological activity of alpha-glucosyl C24:0 and C20:2 ceramides.". Bioorganic & medicinal chemistry letters (2010): http://europepmc.org/abstract/med/20529677.
    10.1016/j.bmcl.2010.05.010
  29. Audouard C; Bettaney K; Doan CT; Rinaudo G; Jervis PJ; Percy JM. "An appraisal of oxoketene cycloaddition methodology for the synthesis of 2,6-dideoxysugars and fluorinated 2,6-dideoxysugars.". Organic & biomolecular chemistry (2009): http://europepmc.org/abstract/med/19343243.
    10.1039/b817672h
  30. Grainer RS; Jervis PJ. "Synthesis by Extrusion". Science of Synthesis (2009): https://science-of-synthesis.thieme.com/app/text/?id=SD-046-00194.
    DOI: 10.1055/sos-SD-046-00194
  31. Jervis PJ; Cox LR. "Total synthesis and proof of relative stereochemistry of (-)-aureonitol.". The Journal of organic chemistry (2008): http://europepmc.org/abstract/med/18774862.
    10.1021/jo801338t
  32. Beignet J; Jervis PJ; Cox LR. "Temporary silicon connection strategies in intramolecular allylation of aldehydes with allylsilanes.". The Journal of organic chemistry (2008): http://europepmc.org/abstract/med/18557649.
    10.1021/jo800824x
  33. Ramalho R; Jervis PJ; Kariuki BM; Humphries AC; Cox LR. "A Brønsted acid mediated cascade enone synthesis from aldehydes containing a tethered propargylsilane.". The Journal of organic chemistry (2008): http://europepmc.org/abstract/med/18197686.
    10.1021/jo702351s
  34. Jervis PJ; Kariuki BM; Cox LR. "Stereoselective synthesis of 3,4-disubstituted tetrahydrofurans and 2,3,4-trisubstituted tetrahydrofurans using an intramolecular allylation strategy employing allylsilanes". Tetrahedron Letters 49 16 (2008): 2514-2518. https://www.sciencedirect.com/science/article/pii/S004040390800316X?via%3Dihub.
    https://doi.org/10.1016/j.tetlet.2008.02.088
  35. Jervis PJ; Cox LR. "Tether-directed synthesis of highly substituted oxasilacycles via an intramolecular allylation employing allylsilanes.". Beilstein journal of organic chemistry (2007): http://europepmc.org/abstract/med/17288602.
    10.1186/1860-5397-3-6
  36. Jervis PJ; Kariuki BM; Cox LR. "Stereoselective synthesis of 2,4,5-trisubstituted tetrahydropyrans using an intramolecular allylation strategy.". Organic letters (2006): http://europepmc.org/abstract/med/16986972.
    10.1021/ol061957v
Poster em conferência
  1. Oliveira, Carlos B.P. ; Jervis, Peter J; hilliou, loic; Ferreira, Paula M.T.; Martins, José A.. "New supramolecular hypergelators based on dehydroamino acid residues for biomedical applications". Trabalho apresentado em XXVI Encontro Galego Português de Química, 2022, 2022.
  2. Oliveira, Carlos B.P. ; Jervis, Peter J; hilliou, loic; Ferreira, Paula M.T.; Martins, José A.. "Development of new supramolecular hypergelators based on non-natural amino acid residues". Trabalho apresentado em ChemBioGels2021 International Symposium, 2021.
  3. Jervis, Peter; hilliou, loic; Renato B Pereira; Pereira, David M.; Martins, Jose A; Paula MT Ferreira. Autor correspondente: Jervis, Peter. "A Model Photo-Caged Dehydropeptide as a Stimuli-Responsive Hydrogel". Trabalho apresentado em INL EuroNanoForum 2021, 2021.
  4. Oliveira, Carlos B.P. ; Jervis, Peter J; Ferreira, Paula M.T.. Autor correspondente: Oliveira, Carlos B.P.. "Synthesis of a new biologically relevant peptide-based hydrogel for biomedical applications". Trabalho apresentado em II Symposium on Applied Biochemistry, 2021, 2021.
  5. Jervis, Peter; Cox, Liam R; Besra, Gurdyal S.. "Synthesis and biological activity activity of novel CD1d glycolipid antigens". Trabalho apresentado em International Carbohydrate Symposium 2014 (Bangalore, India), 2014.
  6. Jervis, Peter; Besra, Gurdyal S.; Cox, Liam R. "Novel glycolipids for activating CD1d-restricted NKT cells". Trabalho apresentado em International Symposium on CD1 and NKT cells 2013 (Tours, France), 2013.
  7. Jervis, Peter; Cox, Liam R; Besra, Gurdyal S.. "Labeled CD1d glycolipid agonists for studying NKT cells". Trabalho apresentado em International Symposium on CD1 and NKT cells 2011 (Chicago, USA), 2011.
  8. Jervis, Peter; Cox, Liam R; Besra, Gurdyal S.. "Synthesis and bioloigical evaluation of 6-N-derivatized alpha-galactosyl ceramides". Trabalho apresentado em Eurocarb conference 2011 (Sorrento, Italy), 2011.
Tese / Dissertação
  1. "Stereoselective intramolecular allylation routes to oxygen-containing heterocycles". Doutoramento, University of Birmingham College of Engineering and Physical Sciences, 2008.
  2. "The synthesis of 2,6-dideoxy- and 2,6-dideoxy-6-fluoro-sugars". Mestrado, University of Leicester, 2004.
Atividades

Apresentação oral de trabalho

Título da apresentação Nome do evento
Anfitrião (Local do evento)
2021/10/22 An injectable, naproxen-conjugated, supramolecular hydrogel with ultra-low critical gelation concentration - prepared from a known folate receptor ligand ChemBioGels2021 International Symposium
(Braga, Portugal)
2021/05/13 Development of new supramolecular hypergelators based on dehydropeptide derivatives. Dar Asas à Investigação
Universidade do Minho, Braga
2021/04/10 Novel hydrogels for drug delivery applications III Jornadas da Ciência
University of Minho (Braga, Portugal)
2012/07/23 Design, Synthesis, and Functional Activity of Labeled CD1d Glycolipid Agonists International Carbohydrate Symposium 2012 (Madrid, Spain)
Madrid (Madrid, Espanha)

Organização de evento

Nome do evento
Tipo de evento (Tipo de participação) 		Instituição / Organização
2021/10/21 - 2021/10/22 ChemBioGels2021 Provided a forum for discussion and dissemination of the scientific area of Supramolecular Materials and their applications. Online platform for the presentation and discussion of emerging topics in Supramolecular Materials with biomedical applications such as controlled drug delivery, cell culture media and tissue engineering, functional textiles and theranostic agents. (2021/10/21 - 2021/10/22) (2021/10/21 - 2021/10/22)
Conferência (Membro da Comissão Organizadora)

Arbitragem científica em revista

Nome da revista (ISSN) Editora
2021/06/03 - Atual Gels MDPI
2021/03/03 - Atual Molecules MDPI
2020/09/29 - Atual Antioxidants MDPI
2020/05/05 - Atual Pharmaceutics MDPI
2020/02/14 - Atual International Journal of Molecular Sciences (1422-0067) MDPI

Consultoria / Parecer

Descrição da atividade Instituição / Organização
2020/04/01 - Atual Guest editor for a Special Issue in the International Journal of Molecular Sciences: "Hydrogels in Regenerative Medicine and Other Biomedical Applications" MDPI AG, Suiça
2017/01/06 - 2017/09/30 STEM ambassador - A STEM Ambassador is a voluntary role undertaken by someone who has a passion and/or professional knowledge of STEM subjects. Our volunteers give their time and enthusiasm to work with young people in schools and in the community, with the shared goal of inspiring the next generation to continue a STEM pathway. This programme is supported by UK Research and Innovation. Concept Life Sciences Chapel-en-le-Frith, Reino Unido
Distinções

Prémio

2007 Winner best poster at Chemistry Postgraduate Symposium 2007
University of Birmingham College of Engineering and Physical Sciences, Reino Unido